The following is a list of the top 100 prescribed medicines by US National Sales in Q2 2012. Figures include sales through both retail and hospital channels, listed by drug name and units sold in the United States.
| Rank |
Drug |
Units (000) |
|
|
1 ( 1) |
acetaminophen/hydrocodone
Generic |
9,529 |
1.59% |
Stats |
2 ( 1) |
budesonide
Generic |
9,330 |
-28.55% |
Stats |
| 3 (2) |
Singulair
Merck & Co., Inc. |
7,142 |
3.72% |
Stats |
| 4 (1) |
ProAir HFA
Teva Pharmaceuticals |
6,728 |
-15.04% |
Stats |
| 5 (1) |
One Touch Ultra
|
6,647 |
-8.93% |
Stats |
| 6 |
Nexium
AstraZeneca Pharmaceuticals |
6,437 |
-2.05% |
Stats |
| 7 |
Cymbalta
Eli Lilly and Company |
6,235 |
2.20% |
Stats |
| 8 |
Lantus
Sanofi-Aventis |
5,782 |
-1.72% |
Stats |
| 9 |
Advair Diskus
GlaxoSmithKline |
5,624 |
-3.10% |
Stats |
| 10 |
Ventolin HFA
GlaxoSmithKline |
5,215 |
-8.57% |
Stats |
| 11 (3) |
atorvastatin
Generic |
4,248 |
12.83% |
Stats |
| 12 (1) |
Crestor
AstraZeneca Pharmaceuticals |
4,036 |
2.80% |
Stats |
| 13 (2) |
fentanyl
Generic |
4,013 |
7.36% |
Stats |
| 14 (2) |
Lantus Solostar
Sanofi-Aventis |
3,917 |
4.82% |
Stats |
| 15 (2) |
enoxaparin
Generic |
3,828 |
9.75% |
Stats |
| 16 (4) |
AndroGel
Abbott Laboratories |
3,516 |
-13.78% |
Stats |
| 17 (1) |
Spiriva
Boehringer Ingelheim Pharmaceuticals, Inc |
3,425 |
0.76% |
Stats |
| 18 (7) |
Plavix
Bristol-Myers Squibb Company |
3,070 |
-41.53% |
Stats |
| 19 |
Novolog
Novo Nordisk Inc. |
3,007 |
0.91% |
Stats |
| 20 (1) |
Levemir
Novo Nordisk Inc. |
2,835 |
3.02% |
Stats |
| 21 (1) |
Nasonex
Merck & Co., Inc. |
2,748 |
-2.48% |
Stats |
| 22 (1) |
NovoLog FlexPen
Novo Nordisk Inc. |
2,655 |
6.67% |
Stats |
| 23 (2) |
metoprolol
Generic |
2,550 |
7.78% |
Stats |
| 24 |
Abilify
Otsuka Pharmaceutical Co. |
2,495 |
0.28% |
Stats |
| 25 (3) |
Humalog
Eli Lilly and Company |
2,465 |
-4.09% |
Stats |
26 ( ) |
Synthroid
Abbott Laboratories |
2,339 |
 |
Stats |
| 27 (1) |
Januvia
Merck & Co., Inc. |
2,298 |
3.19% |
Stats |
| 28 (1) |
Diovan
Novartis Corporation |
2,027 |
-3.43% |
Stats |
| 29 (1) |
Namenda
Forest Pharmaceuticals, Inc |
1,995 |
-2.87% |
Stats |
| 30 (1) |
Lyrica
Pfizer Inc |
1,982 |
-0.45% |
Stats |
| 31 |
Zetia
Merck & Co., Inc. |
1,919 |
-1.69% |
Stats |
| 32 (4) |
Symbicort
AstraZeneca Pharmaceuticals |
1,915 |
3.51% |
Stats |
| 33 (2) |
Suboxone
Reckitt Benckiser Pharmaceuticals Inc. |
1,907 |
1.98% |
Stats |
| 34 (4) |
Combivent
Boehringer Ingelheim Pharmaceuticals, Inc |
1,904 |
-4.23% |
Stats |
| 35 (1) |
Flovent HFA
GlaxoSmithKline |
1,765 |
-6.61% |
Stats |
| 36 (3) |
Actos
Takeda Pharmaceuticals North America, Inc |
1,741 |
-8.94% |
Stats |
| 37 (22) |
escitalopram
Generic |
1,727 |
123.42% |
Stats |
| 38 (1) |
Remicade
Centocor Ortho Biotech, Inc |
1,593 |
2.38% |
Stats |
| 39 (1) |
Lidoderm
Endo Pharmaceuticals |
1,592 |
1.53% |
Stats |
| 40 |
Lovaza
GlaxoSmithKline |
1,549 |
0.78% |
Stats |
| 41 |
Benicar
Daiichi Sankyo |
1,449 |
-1.76% |
Stats |
| 42 (10) |
Lipitor
Pfizer Inc |
1,398 |
-27.90% |
Stats |
| 43 |
Dexilant
Takeda Pharmaceuticals North America, Inc |
1,382 |
3.06% |
Stats |
| 44 (1) |
Restasis
Allergan, Inc |
1,327 |
2.79% |
Stats |
| 45 (2) |
OxyContin
|
1,251 |
0.16% |
Stats |
| 46 |
Diovan HCT
Novartis Corporation |
1,209 |
-3.36% |
Stats |
| 47 (3) |
Vytorin
Merck & Co., Inc. |
1,205 |
-8.16% |
Stats |
| 48 (4) |
VESIcare
Astellas Pharma US |
1,013 |
3.37% |
Stats |
| 49 (4) |
Celebrex
Pfizer Inc |
999 |
2.25% |
Stats |
| 50 (1) |
Pradaxa
Boehringer Ingelheim Pharmaceuticals, Inc |
983 |
-2.77% |
Stats |
| 51 (3) |
Janumet
Merck & Co., Inc. |
974 |
1.56% |
Stats |
| 52 (2) |
Niaspan
Abbott Laboratories |
947 |
-7.61% |
Stats |
| 53 (3) |
Enbrel
Amgen Inc. |
878 |
6.68% |
Stats |
| 54 () |
Evista
Eli Lilly and Company |
863 |
|
Stats |
| 55 |
TriCor
Abbott Laboratories |
802 |
-6.85% |
Stats |
| 56 (2) |
Vyvanse
Shire US Inc |
769 |
-2.78% |
Stats |
| 57 |
Aciphex
Eisai Corporation |
761 |
-3.91% |
Stats |
| 58 (2) |
methylphenidate
Generic |
731 |
-5.19% |
Stats |
| 59 (2) |
Cialis
Eli Lilly and Company |
696 |
5.61% |
Stats |
| 60 (2) |
amphetamine/dextroamphetamine
Generic |
658 |
0.61% |
Stats |
| 61 (3) |
Epogen
Amgen Inc. |
626 |
12.79% |
Stats |
| 62 (4) |
Humira
Abbott Laboratories |
595 |
8.97% |
Stats |
| 63 (2) |
Rituxan
Genentech, Inc |
576 |
5.30% |
Stats |
| 64 (1) |
Truvada
Gilead Sciences, Inc. |
574 |
-0.52% |
Stats |
| 65 (2) |
Rebif
|
572 |
5.93% |
Stats |
| 66 (3) |
Atripla
Gilead Sciences, Inc. |
477 |
-2.45% |
Stats |
| 67 (3) |
Avastin
Genentech, Inc |
476 |
3.48% |
Stats |
| 68 (5) |
Viagra
Pfizer Inc |
448 |
0.45% |
Stats |
| 69 () |
Victoza
Novo Nordisk Inc. |
437 |
|
Stats |
| 70 (1) |
Seroquel XR
AstraZeneca Pharmaceuticals |
432 |
-3.79% |
Stats |
| 71 () |
modafinil
Generic |
396 |
|
Stats |
| 72 (2) |
Adderall XR
Shire US Inc |
378 |
-10.85% |
Stats |
| 73 (3) |
Neulasta
Amgen Inc. |
335 |
1.21% |
Stats |
| 74 (1) |
Lunesta
Sunovion Pharmaceuticals Inc. |
334 |
-4.02% |
Stats |
| 75 (3) |
Orencia
Bristol-Myers Squibb Company |
330 |
5.10% |
Stats |
| 76 (3) |
Procrit
Janssen Pharmaceuticals, Inc |
316 |
7.12% |
Stats |
| 77 () |
Mirena
Bayer Healthcare Pharmaceuticals |
306 |
|
Stats |
| 78 () |
Renvela
Genzyme Corporation |
294 |
|
Stats |
| 79 () |
Varivax
Merck & Co., Inc. |
288 |
|
Stats |
| 80 |
Aranesp
Amgen Inc. |
282 |
-3.75% |
Stats |
| 81 (2) |
Eloxatin
Sanofi-Aventis |
281 |
2.55% |
Stats |
| 82 |
Reyataz
Bristol-Myers Squibb Company |
279 |
-1.76% |
Stats |
| 83 (1) |
Erbitux
Bristol-Myers Squibb Company |
262 |
-1.50% |
Stats |
| 84 (1) |
Isentress
Merck & Co., Inc. |
254 |
4.10% |
Stats |
| 85 (48) |
Seroquel
AstraZeneca Pharmaceuticals |
247 |
-85.07% |
Stats |
| 86 (2) |
Copaxone
Teva Pharmaceuticals |
225 |
6.13% |
Stats |
| 87 (2) |
Prezista
Janssen Pharmaceuticals, Inc |
219 |
5.80% |
Stats |
| 88 (1) |
Lucentis
Genentech, Inc |
213 |
-4.91% |
Stats |
| 89 (1) |
Alimta
Eli Lilly and Company |
187 |
7.47% |
Stats |
| 90 (1) |
Neupogen
Amgen Inc. |
177 |
4.12% |
Stats |
| 91 (2) |
Prevnar 13
Wyeth |
167 |
7.74% |
Stats |
| 92 |
Herceptin
Genentech, Inc |
163 |
5.16% |
Stats |
| 93 (1) |
Velcade
Takeda Pharmaceuticals North America, Inc |
159 |
8.90% |
Stats |
| 94 (1) |
Zyvox
Pfizer Inc |
141 |
-2.76% |
Stats |
| 95 (1) |
Avonex
Biogen Idec |
132 |
1.54% |
Stats |
| 96 (2) |
Gleevec
Novartis Corporation |
84 |
6.33% |
Stats |
| 97 () |
Xeloda
Roche Pharmaceuticals |
66 |
|
Stats |
| 98 (1) |
Betaseron
Bayer Healthcare Pharmaceuticals |
59 |
-11.94% |
Stats |
| 99 () |
Gilenya
Novartis Corporation |
49 |
|
Stats |
| 100 |
Incivek
Vertex Pharmaceuticals |
22 |
-8.33% |
Stats |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
1)
1)
)
